Fleeing India: What Will Make Clinical Trials Flood Back
India’s clinical trial industry has seen it all. In less than 10 years, the country has grown to become a leading destination for clinical trials, attracting studies from multinational pharma companies and contract research organizations. This however is no longer the case as the once skyrocket growth has now come to a brutal end. If India’s clinical trial industry is to pick up again, a major restructuring of its regulatory system will have to take place.
To continue reading this story get free access
Please note: That all fields marked with an asterisk (*) are required.